Study of Mogamulizumab + MEDI4736 (Durvalumab) and Mogamulizumab + Tremelimumab in Subjects w/ Advanced Solid Tumors
Clinical trial NCT02301130 · COMPLETED
Trial details
- NCT number
- NCT02301130
- Sponsor
- Kyowa Kirin, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-26
- Primary completion
- 2017-12-08
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.